Capitolis Liquid Global Markets LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 11.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 699,000 shares of the company's stock after purchasing an additional 74,000 shares during the period. Capitolis Liquid Global Markets LLC owned approximately 0.09% of Colgate-Palmolive worth $63,546,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC purchased a new stake in Colgate-Palmolive in the 4th quarter worth about $26,000. Centricity Wealth Management LLC purchased a new stake in Colgate-Palmolive in the 4th quarter worth approximately $27,000. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive during the fourth quarter valued at $32,000. Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive in the 4th quarter worth about $32,000. Finally, Wintrust Investments LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $33,000. Institutional investors own 80.41% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on CL shares. TD Cowen reduced their target price on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. UBS Group boosted their target price on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research report on Thursday, April 17th. JPMorgan Chase & Co. lifted their price objective on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. Raymond James reaffirmed an "outperform" rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, Barclays dropped their price objective on shares of Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, April 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of "Moderate Buy" and a consensus target price of $102.39.
Get Our Latest Report on CL
Colgate-Palmolive Stock Up 0.3 %
Colgate-Palmolive stock opened at $90.75 on Tuesday. The company has a 50 day moving average of $92.27 and a 200-day moving average of $91.72. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The stock has a market capitalization of $73.55 billion, a PE ratio of 25.78, a price-to-earnings-growth ratio of 4.20 and a beta of 0.39.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. Colgate-Palmolive's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.86 EPS. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be paid a dividend of $0.52 per share. The ex-dividend date is Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.29%. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.
Colgate-Palmolive declared that its board has initiated a share buyback program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 6.8% of its stock through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its shares are undervalued.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.